Conserved sequence-specific lincRNA-steroid receptor interactions drive transcriptional repression and direct cell fate

Nature Communications

Volumn 5, Issue , 2014, Pages

  Hudson, William H ^a,b   Pickard, Mark R ^c   De Vera, Ian Mitchelle S ^d   Kuiper, Emily G ^a   Mourtada Maarabouni, Mirna ^c   Conn, Graeme L ^a   Kojetin, Douglas J ^d   Williams, Gwyn T ^c   Ortlund, Eric A ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMORY UNIVERSITY   (United States)

^c KEELE UNIVERSITY   (United Kingdom)

^d SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH ARREST SPECIFIC 5 PROTEIN; LONG UNTRANSLATED RNA; RNA BINDING PROTEIN; STEROID RECEPTOR; UNCLASSIFIED DRUG; GROWTH ARREST SPECIFIC TRANSCRIPT 5; SMALL NUCLEOLAR RNA;

CANCER; EUKARYOTE; EVOLUTIONARY BIOLOGY; GENE EXPRESSION; GENOME; MUTATION; RNA; STEROID;

ALTERNATIVE RNA SPLICING; APOPTOSIS; ARTICLE; BINDING AFFINITY; CANCER CELL LINE; CELL FATE; CELL GROWTH; CONTROLLED STUDY; GENE REPRESSION; HAPLOTYPE; HUMAN; HUMAN CELL; MALE; MOLECULAR EVOLUTION; MOLECULAR RECOGNITION; NUCLEOTIDE BINDING SITE; NUCLEOTIDE SEQUENCE; POINT MUTATION; PROTEIN PROTEIN INTERACTION; PROTEIN RNA BINDING; PROTEIN TARGETING; TRANSCRIPTION REGULATION; AMINO ACID SEQUENCE; BIOLOGICAL MODEL; BREAST TUMOR; CELL PROLIFERATION; CHEMISTRY; CONSERVED SEQUENCE; DNA RESPONSIVE ELEMENT; FEMALE; GENETIC TRANSCRIPTION; GENETICS; MUTATION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOLOGY; PHYSIOLOGY; PROSTATE TUMOR; TUMOR CELL LINE;

EUKARYOTA;

AMINO ACID SEQUENCE; APOPTOSIS; BASE SEQUENCE; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; CONSERVED SEQUENCE; FEMALE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MODELS, GENETIC; MUTATION; PROSTATIC NEOPLASMS; RECEPTORS, STEROID; RESPONSE ELEMENTS; RNA, LONG NONCODING; RNA, SMALL NUCLEOLAR; TRANSCRIPTION, GENETIC;

EID: 84923289387     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms6395     Document Type: Article

References (70)

1. Galperin, M. Y. & Koonin, E. V. From complete genome sequence to 'complete' understanding? Trends Biotechnol. 28, 398-406 (2010).
2. Consortium, I.H.G.S. Initial sequencing and analysis of the human genome. Nature 409, 860-921 (2001).
3. Kapranov, P. et al. The majority of total nuclear-encoded non-ribosomal RNA in a human cell is 'dark matter' un-annotated RNA. BMC Biol. 8, 149-149 (2010).
4. Khalil, A. M. & Rinn, J. L. RNA-protein interactions in human health and disease. Semin. Cell Dev. Biol. 22, 359-365 (2011).
5. Guttman, M. et al. Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature 458, 223-227 (2009).
6. Guttman, M. et al. lincRNAs act in the circuitry controlling pluripotency and differentiation. Nature 477, 295-300 (2011).
7. Huarte, M. et al. A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response. Cell 142, 409-419 (2010).
8. Loewer, S. et al. Large intergenic non-coding RNA-RoR modulates reprogramming of human induced pluripotent stem cells. Nat. Genet. 42, 1113-1117 (2010).
9. Sharma, S. et al. Dephosphorylation of the nuclear factor of activated T cells (NFAT) transcription factor is regulated by an RNA-protein scaffold complex. Proc. Natl Acad. Sci. USA 108, 11381-11386 (2011).
10. Guttman, M. et al. Ab initio reconstruction of cell type-specific transcriptomes in mouse reveals the conserved multi-exonic structure of lincRNAs. Nature Biotechnol. 28, 503-510 (2010).
11. Ponjavic, J., Ponting, C. P. & Lunter, G. Functionality or transcriptional noise? Evidence for selection within long noncoding RNAs. Genome Res. 17, 556-565 (2007).
12. Ulitsky, I., Shkumatava, A., Jan, C. H., Sive, H. & Bartel, D. P. Conserved function of lincRNAs in vertebrate embryonic development despite rapid sequence evolution. Cell 147, 1537-1550 (2011).
13. Tsai, M.-C. et al. Long Noncoding RNA as Modular Scaffold of Histone Modification Complexes. Science 392, 689-693 (2010).
14. Kino, T., Hurt, D. E., Ichijo, T., Nader, N. & Chrousos, G. P. Noncoding RNA gas5 is a growth arrest- and starvation-associated repressor of the glucocorticoid receptor. Sci. Signal 3, ra8-ra8 (2010).
15. Frankish, A., Mudge, J. M., Thomas, M. & Harrow, J. The importance of identifying alternative splicing in vertebrate genome annotation. Database 2012 (2012).
16. Higa-Nakamine, S. et al. Loss of ribosomal RNA modification causes developmental defects in zebrafish. Nucleic Acids Res. 40, 391-398 (2011).
17. Gibb, E. A. et al. Human cancer long non-coding RNA transcriptomes. PLoS ONE 6, e25915-e25915 (2011).
18. Mourtada-Maarabouni, M., Hedge, V. L., Kirkham, L., Farzaneh, F. & Williams, G. T. Growth arrest in human T-cells is controlled by the non-coding RNA growth-arrest-specific transcript 5 (GAS5). J. Cell Sci. 123, 1181-1181 (2010).
19. Schneider, C., King, R. M. & Philipson, L. Genes specifically expressed at growth arrest of mammalian cells. Cell 54, 787-793 (1988).
20. Mourtada-Maarabouni, M., Hasan, A. M., Farzaneh, F. & Williams, G. T. Inhibition of human T-cell proliferation by mammalian target of rapamycin (mTOR) antagonists requires noncoding RNA growth-arrest-specific transcript 5 ( GAS5 ). Mol. Pharmacol. 78, 19-28 (2010).
21. Mourtada-Maarabouni, M., Pickard, M. R., Hedge, V. L., Farzaneh, F. & Williams, G. T. GAS5, a non-protein-coding RNA, controls apoptosis and is downregulated in breast cancer. Oncogene 28, 195-208 (2009).
22. Pickard, M. R., Mourtada-Maarabouni, M. & Williams, G. T. Long non-coding RNA GAS5 regulates apoptosis in prostate cancer cell lines. Biochim. Biophys. Acta 1832, 1613-1623 (2013).
23. Meijsing, S. H. et al. DNA binding site sequence directs glucocorticoid receptor structure and activity. Science 324, 407-410 (2009).
24. Schwabe, J. W. R., Chapman, L., Finch, J. T. & Rhodes, D. The crystal structure of the estrogen receptor DNA-binding domain bound to DNA: how receptors discriminate between their response elements. Cell 75, 567-578 (1993).
25. Tolbert, B. S. et al. Major groove width variations in RNA structures determined by NMR and impact of 13C residual chemical shift anisotropy and 1H-13C residual dipolar coupling on refinement. J. Biomol. NMR 47, 205-219 (2010).
26. Hudson, W. H., Youn, C. & Ortlund, E. A. The structural basis of direct glucocorticoid-mediated transrepression. Nat. Struct. Mol. Biol. 20, 53-58 (2013).
27. Battiste, J. L. et al. Helix-RNA major groove recognition in an HIV-1 Rev peptide-RRE RNA complex. Science 273, 1547-1551 (1996).
28. Weeks, K. & Crothers, D. Major groove accessibility of RNA. Science 261, 1574-1577 (1993).
29. Watson, L. C. et al. The glucocorticoid receptor dimer interface allosterically transmits sequence-specific DNA signals. Nat. Struct. Mol. Biol 20, 876-883 (2013).
30. Luisi, B. F. et al. Crystallographic analysis of the interaction of the glucocorticoid receptor with DNA. Nature 352, 497-505 (1991).
31. de Vries, S. J., van Dijk, M. & Bonvin, A.M.J.J. The HADDOCK web server for data-driven biomolecular docking. Nat. Protoc. 5, 883-897 (2010).
32. Strobel, S. & Cech, T. Minor groove recognition of the conserved G.U pair at the Tetrahymena ribozyme reaction site. Science 267, 675-679 (1995).
33. Magali, F. & Schimmel, P. Subtle atomic group discrimination in the RNA minor groove. Proc. Natl Acad. Sci. USA 94, 11291-11294 (1997).
34. Romanuik, T. L. et al. LNCaP Atlas: gene expression associated with in vivo progression to castration-recurrent prostate cancer. BMC Med. Genomics 3, 43 (2010).
35. John, S. et al. Chromatin accessibility pre-determines glucocorticoid receptor binding patterns. Nature Genet. 43, 264-268 (2011).
36. Shu, Z. & Bevilacqua, P. C. Isolation and characterization of thermodynamically stable and unstable RNA hairpins from a Triloop Combinatorial Library. Biochemistry 38, 15369-15379 (1999).
37. Hirose, T. & Steitz, J. A. Position within the host intron is critical for efficient processing of box C/D snoRNAs in mammalian cells. Proc. Natl Acad. Sci. USA 98, 12914-12919 (2001).
38. Batzer, M. A. & Deininger, P. L. Alu repeats and human genomic diversity. Nat. Rev. Genet. 3, 370-379 (2002).
39. Surjit, M. et al. Widespread negative response elements mediate direct repression by agonist-liganded glucocorticoid receptor. Cell 145, 224-241 (2011).
40. Ali, M. & Vedeckis, W. The glucocorticoid receptor protein binds to transfer RNA. Science 235, 467-470 (1987).
41. Ishmael, F. T. et al. The human glucocorticoid receptor as an RNA-binding protein: global analysis of glucocorticoid receptor-associated transcripts and identification of a target RNA motif. J. Immunol. 186, 1189-1198 (2011).
42. Hudson, W. H. & Ortlund, E. A. Proteins that bind DNA and RNA: structure, function, and evolution. Nat. Rev. Mol. Cell. Biol 15, 749-760 (2014).
43. Huang, D.-B. et al. Crystal structure of NF-kB (p50)2 complexed to a highaffinity RNA aptamer. Proc. Natl Acad. Sci. USA 100, 9268-9273 (2003).
44. Müller, C. W., Rey, F. A., Sodeoka, M., Verdine, G. L. & Harrison, S. C. Structure of the NF-kB p50 homodimer bound to DNA. Nature 373, 311-317 (1995).
45. Presman, D. M. et al. Live cell imaging unveils multiple domain requirements for in vivo dimerization of the glucocorticoid receptor. PLoS Biol. 12, e1001813 (2014).
46. Cote, G. J. & Gagel, R. F. Dexamethasone differentially affects the levels of calcitonin and calcitonin gene-related peptide mRNAs expressed in a human medullary thyroid carcinoma cell line. J. Biol. Chem. 261, 15524-15528 (1986).
47. Kosaki, A. & Webster, N. J. Effect of dexamethasone on the alternative splicing of the insulin receptor mRNA and insulin action in HepG2 hepatoma cells. J. Biol. Chem. 268, 21990-21996 (1993).
48. Lai, G.-J. & McCobb, D. P. Opposing actions of adrenal androgens and glucocorticoids on alternative splicing of Slo potassium channels in bovine chromaffin cells. Proc. Natl Acad. Sci. USA 99, 7722-7727 (2002).
49. Webster, J. C. & Cidlowski, J. A. Mechanisms of Glucocorticoid-receptormediated repression of gene expression. Trends Endocrinol. Metab. 10, 396-402 (1999).
50. Flicek, P. et al. Ensembl 2011. Nucleic Acids Res. 39, D800-D806 (2011).
51. Schorderet, P. & Duboule, D. Structural and functional differences in the long non-coding RNA hotair in mouse and human. PLoS Genet. 7, e1002071 (2011).
52. Hudson, W. H., Youn, C. & Ortlund, E. A. Crystal structure of the mineralocorticoid receptor DNA binding domain in complex with DNA. PLoS One 9, e107000 (2014).
53. Easton, L. E., Shibata, Y. & Lukavsky, P. J. Rapid, nondenaturing RNA purification using weak anion-exchange fast performance liquid chromatography. RNA 16, 647-653 (2010).
54. Wahid, A. M., Coventry, V. K. & Conn, G. L. The PKR-binding domain of adenovirus VA RNAI exists as a mixture of two functionally non-equivalent structures. Nucleic Acids Res. 37, 5830-5837 (2009).
55. Emsley, P. & Cowtan, K. Coot: model-building tools for molecular graphics. Acta Crystallogr. D60, 2126-2132 (2004).
56. Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D66, 213-221 (2010).
57. Lu, X.-J. & Olson, W. K. 3DNA: a versatile, integrated software system for the analysis, rebuilding and visualization of three-dimensional nucleic-acid structures. Nat. Protoc. 3, 1213-1227 (2008).
58. Williamson, M. P. Using chemical shift perturbation to characterise ligand binding. Prog. Nucl. Mag. Res. Sp 73, 1-16 (2013).
59. Johnson, B. in Protein NMR Techniques Vol. 278 (ed. Downing, A. K.) 313-352 (Humana, 2004).
60. Case, D. A. et al. The Amber biomolecular simulation programs. J. Comput. Chem. 26, 1668-1688 (2005).
61. Jorgensen, W. L., Chandrasekhar, J., Madura, J. D., Impey, R. W. & Klein, M. L. Comparison of simple potential functions for simulating liquid water. J. Biol. Chem. 79, 926-935 (1983).
62. Gotz, A. W. et al. Routine microsecond molecular dynamics simulations with AMBER on GPUs. 1. Generalized Born. J. Chem. Theory Comput. 8, 1542-1555 (2012).
63. Le Grand, S., Götz, A. W. & Walker, R. C. SPFP: Speed without compromise' A mixed precision model for GPU accelerated molecular dynamics simulations. Comput. Phys. Commun. 184, 374-380 (2013).
64. Shang, Y. & Simmerling, C. Molecular dynamics applied in drug discovery: the case of HIV-1 protease. Methods Mol. Biol. 819, 527-549 (2012).
65. Allen, M. P. & Tildesley, D. J. Computer Simulation of Liquids (Oxford Univ., 1987).
66. Ryckaert, J.-P., Ciccotti, G. & Berendsen, H. J. C. Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes. J. Comput. Phys. 23, 327-341 (1977).
67. Williams, G. T., Critchlow, M. R., Hedge, V. L. & O'Hare, K. B. Molecular failure of apoptosis: inappropriate cell survival and mutagenesis? Toxicol. Lett. 102-103, 485-489 (1998).
68. Pickard, M. R., Darling, D., Farzaneh, F. & Williams, G. T. Preparation and characterization of prostate cell lines for functional cloning studies to identify regulators of apoptosis. J. Androl. 30, 248-258 (2009).
69. Reese, M., Eeckman, F., Kulp, D. & Haussler, D. Improved Splice Site Detection in Genie. J. Comput. Biol. 4, 311-323 (1997).
70. Tamura, K. et al. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol. Biol. Evol. 28, 2731-2739 (2011).